Atıf Formatları
A new drug combination for hormone and drug refractory prostate cancer All Trans Retinoic Acid ATRA and zoledronic acid
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

Ş. B. KARACA Et Al. , "A new drug combination for hormone and drug refractory prostate cancer All Trans Retinoic Acid ATRA and zoledronic acid," 3rd International Meeting on Medicinal and Pharmaceutical Chemistry , pp.3, 2007

KARACA, Ş. B. Et Al. 2007. A new drug combination for hormone and drug refractory prostate cancer All Trans Retinoic Acid ATRA and zoledronic acid. 3rd International Meeting on Medicinal and Pharmaceutical Chemistry , 3.

KARACA, Ş. B., erten, ç., görümlü, g., cengiz, e., GÜL, M. K., KÜÇÜKZEYBEK, Y., ... asbagh, l.(2007). A new drug combination for hormone and drug refractory prostate cancer All Trans Retinoic Acid ATRA and zoledronic acid . 3rd International Meeting on Medicinal and Pharmaceutical Chemistry (pp.3).

KARACA, ŞAZİYE Et Al. "A new drug combination for hormone and drug refractory prostate cancer All Trans Retinoic Acid ATRA and zoledronic acid," 3rd International Meeting on Medicinal and Pharmaceutical Chemistry, 2007

KARACA, ŞAZİYE B. Et Al. "A new drug combination for hormone and drug refractory prostate cancer All Trans Retinoic Acid ATRA and zoledronic acid." 3rd International Meeting on Medicinal and Pharmaceutical Chemistry , pp.3, 2007

KARACA, Ş. B. Et Al. (2007) . "A new drug combination for hormone and drug refractory prostate cancer All Trans Retinoic Acid ATRA and zoledronic acid." 3rd International Meeting on Medicinal and Pharmaceutical Chemistry , p.3.

@conferencepaper{conferencepaper, author={ŞAZİYE BURÇAK KARACA Et Al. }, title={A new drug combination for hormone and drug refractory prostate cancer All Trans Retinoic Acid ATRA and zoledronic acid}, congress name={3rd International Meeting on Medicinal and Pharmaceutical Chemistry}, city={}, country={}, year={2007}, pages={3} }